Guardant Health
360Dx Top 30 Rockets 10 Percent in January
Of the 30 companies included, 19 companies saw their stock price increase, eight firms saw their share price decrease, and three companies remained essentially flat.
In Brief This Week: Beckman Coulter, Quest Diagnostics, Guardant Health, Diasorin, More
News items for the week of Jan. 27, 2025.
Barclays Initiates Coverage of Guardant Health, Exact Sciences, Natera With Overweight Rating
The investment firm cited large, unpenetrated markets for liquid biopsy in residual disease detection, monitoring, and screening.
Guardant Health Reveal Assay Gets Additional Medicare Coverage for CRC Surveillance Testing
The test was previously covered for use in colorectal cancer patients in the early postsurgical setting only.
Guardant Health, ConcertAI Partner on Combined Clinicogenomic Data-as-a-Service Offering
The companies aim to support novel drug development by providing biopharma researchers with longitudinal genomic test results paired with clinical EMR data.
Jan 2, 2025
360Dx Top 30 Falls 4 Percent in December
Oct 29, 2024
Sep 3, 2024
360Dx Top 30 Ticks up 2 Percent in August
Jun 14, 2024